Jukka Peltola, Albert J Colon, José Pimentel, Volker A Coenen, Antonio Gil-Nagel, Antonio Gonçalves Ferreira, Kai Lehtimäki, Philippe Ryvlin, Rod S Taylor, Linda Ackermans, Jacqueline Ardesch, Carla Bentes, Magdalena Bosak, Jorge G Burneo, Clara Chamadoira, Christian E Elger, Loránd Erőss, Dániel Fabo, Howard Faulkner, Jacek Gawlowicz, Alireza Gharabaghi, Maurizio Iacoangeli, Jozsef Janszky, Soila Järvenpää, Elisabeth Kaufmann, Kuan H Kho, Eva Kumlien, Helmut Laufs, Christian Lettieri, Paulo Linhares, Soheyl Noachtar, Andrew Parrent, Ekaterina Pataraia, Nikunj K Patel, Ana Rita Peralta, Attila Rácz, Alexandre Rainha Campos, Ricardo Rego, Riccardo A Ricciuti, Sabine Rona, Rob P W Rouhl, Andreas Schulze-Bonhage, Rick Schuurman, Mathieu Sprengers, Albert Sufianov, Yasin Temel, Tom Theys, Wim Van Paesschen, Dirk Van Roost, Rui Vaz, Kristl Vonck, Louis Wagner, Jack Zwemmer, Abdallah Abouihia, Thomas C Brionne, Frans Gielen, Paul A J M Boon
and ObjectivesThe efficacy of deep brain stimulation of the anterior nucleus of the thalamus (ANT DBS) in drug resistant epilepsy (DRE) patients was demonstrated in the double-blind Stimulation of theAnterior Nucleus of the Thalamus for Epilepsy (SANTE) randomized controlled trial. The Medtronic Registry for Epilepsy (MORE) aims to understand the safety and longer-term effectiveness of ANT DBS therapy in routine clinical practice.MethodsMORE is an observational registry collecting prospective and retrospective clinical data...
March 16, 2023: Neurology